Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma

Clinical trial NCT00715208 · COMPLETED

Trial details

NCT number: NCT00715208
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Follicular Lymphoma

Start date: 2008-09-01
Primary completion: 2011-02-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.